Journal article
The emerging role of low-molecular-weight heparin in cardiovascular medicine
Abstract
Although unfractionated heparin is widely used in the treatment of acute coronary syndromes, it has several pharmacokinetic, biophysical, and biological limitations. The practical advantages and success of low-molecular-weight heparin administered subcutaneously without laboratory monitoring for the treatment of venous thromboembolism have prompted a number of randomized studies investigating the efficacy and safety of these agents in patients …
Authors
Hirsh J; Bates SM
Journal
Progress in Cardiovascular Diseases, Vol. 42, No. 4, pp. 235–246
Publisher
Elsevier
Publication Date
February 2000
DOI
10.1053/pcad.2000.0420235
ISSN
0033-0620